Kenvue fights back against RFK Jr.’s Tylenol safety concerns as its stock tumbles

Kenvue rushed to the defense of Tylenol, but the stock still suffered a record selloff on news that RFK Jr. will release a report linking the use of acetaminophen during pregnancy to autism.

Previous Article

Do Doctors Make Money Off Vaccines? A Look At Incentives And Bonus Structures

Next Article

How you can still get a refund for a delayed or canceled flight even as Trump scraps Biden’s airline compensation proposal

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

79 − 77 =
Powered by MathCaptcha

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨